Echelon Wealth Partners analyst Andrew Semple reiterated a Buy rating on Trulieve Cannabis (TCNNF - Research Report) yesterday and set a price target of C$40.00. The company's shares closed today at $11.08.According to TipRanks, Semple is an analyst with an average return of -4.3% and a 21.95% success rate. Semple covers the Basic Materials sector, focusing on stocks such as Verano Holdings, MariMed, and Fire & Flower Holdings.Trulieve Cannabis has an analyst consensus of Strong Buy, with a price target consensus of $28.07, which is a 153.34% upside from current levels. In a report released yesterday, Needham also maintained a Buy rating on the stock with a $20.00 price target.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-remains-a-buy-on-trulieve-cannabis-tcnnf?utm_source=advfn.com&utm_medium=referral
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2023 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.